![Jonathan Hepple](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Jonathan Hepple
Director/Miembro de la Junta en Nucleome Therapeutics Ltd. .
Origen de la red de primer grado Jonathan Hepple.
Entidad | Tipo de entidad | Industria | |
---|---|---|---|
University of Cambridge
284
| College/University | Other Consumer Services | 284 |
University of Oxford
251
| College/University | Other Consumer Services | 251 |
Oxford Science Enterprises PLC
![]() Oxford Science Enterprises PLC Investment ManagersFinance Oxford Science Enterprises PLC (Oxford Science Enterprises) is a venture capital firm founded in 2015. The firm is headquartered in Oxford, United Kingdom.
55
| Holding Company | Investment Managers | 55 |
MISSION Therapeutics Ltd.
![]() MISSION Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology MISSION Therapeutics Ltd. develops small molecule drugs targeting enzymes involved in cancer and other diseases. It focuses on selectively targeting deubiquitylating enzymes to treat cancer, neurodegenerative and other diseases. The company was founded by Stephen Jackson Philip, Xavier Jacq, Niall M. B. Martin and Keith Menear in 2011 and is headquartered in Cambridge, the United Kingdom.
14
| Holding Company | Pharmaceuticals: Major | 14 |
Public Company | Pharmaceuticals: Major | 11 | |
Rosetta Capital Ltd.
![]() Rosetta Capital Ltd. Investment ManagersFinance Rosetta Capital Ltd (Rosetta Capital) is a venture capital firm is founded in 2001 by Jeremy Curnock Cook, Michael Forer and Jonathan Hepple. The firm is headquartered in London.
8
| Private Company | Investment Managers | 8 |
Carrick Therapeutics Ltd.
![]() Carrick Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Carrick Therapeutics Ltd. manufactures cancer therapeutics. The company is headquartered in Dublin, Ireland.
7
| Holding Company | Pharmaceuticals: Major | 7 |
Nucleome Therapeutics Ltd.
![]() Nucleome Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Nucleome Therapeutics Ltd. develops small molecular drugs for autoimmune diseases. The company was founded by Danuta Mariola Jeziorska, James Raymond Hughes and James Davies and is headquartered in Oxford, the United Kingdom.
2
| Holding Company | Pharmaceuticals: Major | 2 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Jonathan Hepple a través de su red personal
Empresa | Sector | Personas relacionadas | Puesto principal |
---|---|---|---|
ROCHE HOLDING AG | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
Medarex, Inc.
![]() Medarex, Inc. Miscellaneous Commercial ServicesCommercial Services Medarex, Inc. provides commercial physical and biological research services. The company's UltiMAb, a human antibody development system creates and develops antibodies products for cancer, rheumatoid arthritis, inflammatory, autoimmune, and infectious diseases. The company was founded in 1987 and is headquartered in Princeton, New Jersey. | Miscellaneous Commercial Services | Director of Finance/CFO Director of Finance/CFO | |
INTEGRA LIFESCIENCES HOLDINGS CORPORATION | Medical Specialties | Director/Board Member Director of Finance/CFO | |
MORGAN STANLEY | Investment Managers | President Corporate Officer/Principal | |
Genzyme Corp.
![]() Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal | |
Novartis Oncology, Inc.
![]() Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Novartis Oncology, Inc. provides healthcare solutions. The firm offers medicines, eye care and generic pharmaceuticals. It also offers patient declaration, patient support and assistance, and additional resources. The company is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Omthera Pharmaceuticals, Inc.
![]() Omthera Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Omthera Pharmaceuticals, Inc. operates as pharmaceuticals company which focuses on the clinical development of new therapies for dyslipidemia. The company was founded by Jerry Wisler and Michael Davidson in 2008 and is headquartered in Princeton, NJ. | Pharmaceuticals: Major | Director of Finance/CFO Director/Board Member | |
McKinsey & Co., Inc.
![]() McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
GSK Equity Investments Ltd.
![]() GSK Equity Investments Ltd. Investment ManagersFinance GSK Equity Investment Ltd (GSK Equity) is a venture capital firm a subsidiary of GlaxoSmithKline Plc founded in 1985. The firm is headquartered in Reedwood City, California. | Investment Managers | Corporate Officer/Principal Private Equity Investor Corporate Officer/Principal | |
Harvard University
![]() Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Masters Business Admin Doctorate Degree Doctorate Degree | |
Stanford University | College/University | Undergraduate Degree Corporate Officer/Principal | |
Powderject Pharmaceuticals Plc
![]() Powderject Pharmaceuticals Plc Medical SpecialtiesHealth Technology Powderject Pharmaceuticals Plc develops pharmaceutical products. It offers researching, developing, manufacturing and marketing for existing and next generation vaccines. The company was founded in 1993 and is located in Oxford, UK | Medical Specialties | Chief Tech/Sci/R&D Officer Founder | |
PINEWOOD TECHNOLOGIES GROUP PLC | Packaged Software | Chairman Director/Board Member | |
The University of Liverpool
![]() The University of Liverpool Other Consumer ServicesConsumer Services The University of Liverpool operates as a university. It offers post graduate research, foundation courses, continuing and professional development, online study, and doctoral college. The company was founded in 1881 and is headquartered in Liverpool, the United Kingdom. | College/University | Corporate Officer/Principal Undergraduate Degree | |
The University of Southampton | College/University | Corporate Officer/Principal Undergraduate Degree | |
Royal Academy of Engineering | College/University | Corporate Officer/Principal Chairman | |
Princeton University | College/University | Undergraduate Degree Undergraduate Degree Graduate Degree | |
University of Wisconsin | College/University | Doctorate Degree Doctorate Degree | |
University of Durham | College/University | Undergraduate Degree Graduate Degree Graduate Degree | |
NEXSTIM PLC | Medical Specialties | Director/Board Member Director/Board Member | |
The University of Nottingham | College/University | Doctorate Degree Graduate Degree | |
ABIONYX PHARMA | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Glasgow Caledonian University | College/University | Doctorate Degree Graduate Degree | |
Academy of Medical Sciences
![]() Academy of Medical Sciences Miscellaneous Commercial ServicesCommercial Services The Academy of Medical Sciences was founded in 1998 and provides biomedical and health research services. The non-profit company is based in London, UK. | Miscellaneous Commercial Services | President Corporate Officer/Principal | |
Cerenis Therapeutics, Inc.
![]() Cerenis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Cerenis Therapeutics, Inc. discovers, develops and commercializes drugs for the treatment of cardiovascular and metabolic diseases. It focuses on discovery, development, and commercialization of HDL therapies. Cerenis Therapeutics is located in Ann Arbor, MI. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
MONETA MONEY BANK | Regional Banks | Chairman Director/Board Member | |
Aprea Therapeutics AB
![]() Aprea Therapeutics AB Pharmaceuticals: MajorHealth Technology Aprea Therapeutics AB operates as a holding company that provides research performed at Karolinska Institutet. It focuses its activities on discovery and development of novel anticancer compounds targeting the tumor suppressor protein. Its product has been tested in a Phase I/II dose escalating safety study in patients with refractory hematological malignancies or prostate carcinoma. It pursues the development of an anticancer drug, APR-246, which has p53-based mechanism for patients with ovarian cancer. The company was founded by Klas Gosta Wiman, Galina Selivanova, Vladimir Bykov, Wenjie Bao, Natalia Issaeva, and Staffan Strömblad in 2003 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Chairman Chief Executive Officer Director/Board Member Director/Board Member Director/Board Member Director of Finance/CFO | |
LEONTEQ AG | Investment Banks/Brokers | Chairman Director/Board Member | |
BioCity Group Ltd
![]() BioCity Group Ltd Investment ManagersFinance BioCity Group Ltd (BioCity) is a venture capital firm founded in 2002. The firm is headquartered in London, United Kingdom. | Investment Managers | Private Equity Investor Director/Board Member | |
Crescendo Biologics Ltd.
![]() Crescendo Biologics Ltd. Miscellaneous Commercial ServicesCommercial Services Crescendo Biologics Ltd. engages in the development of new medicines based on antibody fragment technology. Its products in pipeline in dermatology include CB001, a transformational Humabody-based topical biologic for psoriasis which combines exceptional activity against a validated target with a topical route of delivery to avoid systemic side effects. The firm?s oncology products in pipeline include Humabody Multi-Specific T-Cell Engagers, Humabody Antibody Drug Conjugates and Immune Checkpoint Inhibitors. The company was founded by Michael Anthony Romanos, David Rayll Brown and John Bradshaw on November 13, 2007 and is headquartered in Cambridge, the United Kingdom. | Miscellaneous Commercial Services | Chairman Director/Board Member | |
C4X Discovery Ltd.
![]() C4X Discovery Ltd. Pharmaceuticals: MajorHealth Technology C4X Discovery Ltd. engages in the discovery and development of medical drugs. It uses its NMR-based technology to solve the dynamic 3D structures of a broad range of biomolecules, including peptides, cofactors, oligonucleotides and carbohydrates. The company was founded by Andrew Almond and Charles Douglas Blundell in January 2008 and is headquartered in Manchester, the United Kingdom. | Pharmaceuticals: Major | Chief Executive Officer Chief Tech/Sci/R&D Officer | |
CEMBRA MONEY BANK AG | Regional Banks | Director/Board Member Director/Board Member | |
Akinion Pharmaceuticals AB
![]() Akinion Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Akinion Pharmaceuticals AB operates as a holding company that focuses on the development of pharmaceutical for the treatment of acute myeloid leukemia. It develops, markets, and sells a product based on Biovitrum’s anti leukemia kinase inhibitor research. It is a drug development that manufactures a lead candidate drug, AKN-028, which is a small molecule kinase inhibitor. The company was founded by Vendela Parrow in 2009 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Chairman Director/Board Member | |
Second Genome, Inc.
![]() Second Genome, Inc. BiotechnologyHealth Technology Second Genome, Inc. develops microbiome-based therapeutic products. It offers phyclochip community, 16S sequencing community analysis, whole metagenomic profiling, nucleic acid isolation, inferred function and custom informatics services. The company was founded in 2009 by Corey S. Goodman, Janet A. Warrington, Todd Z. DeSantis, John Hulls and Gary Andersen and is headquartered in South San Francisco, CA. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
Atopix Therapeutics Ltd.
![]() Atopix Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Atopix Therapeutics Ltd. develops medicines to treat atopic dermatitis and severe asthma. The firm also assess the safety and pharmacokinetic profile of its back-up molecule ATX2417 in a phase I study. The company was incorporated on October 10, 2012 and is headquartered in Abingdon, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin | |
C4X DISCOVERY HOLDINGS PLC | Pharmaceuticals: Major | Chief Executive Officer Chief Tech/Sci/R&D Officer | |
Mironid Ltd.
![]() Mironid Ltd. Pharmaceuticals: MajorHealth Technology Mironid Ltd. develops proprietary drug candidate molecules by modulating the activity of key cell signalling proteins. The company was founded by Miles Houslay, Paul Barton Rodgers, Elizabeth Fairley, Julia Adam, David Adams and Nigel Pyne in 2014 and is headquartered in North Lanarkshire, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Oxford Nanoimaging Ltd.
![]() Oxford Nanoimaging Ltd. Packaged SoftwareTechnology Services Oxford Nanoimaging Ltd. develops and researches intelligent software and fluorescence microscopy image cells. The company was founded by Achillefs Kapanidis and Bo Jing on February 24, 2016 and is headquartered in Oxford, the United Kingdom. | Packaged Software | Director/Board Member Director/Board Member | |
Novira Therapeutics LLC
![]() Novira Therapeutics LLC Pharmaceuticals: MajorHealth Technology Novira Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. It focuses on the discovery and development of therapies for the treatment of chronic hepatitis B (CHB) infection. The firm’s novel antiviral drug candidates addresses the limitations of CHB therapies. The company was founded in 2009 by Osvaldo Flores, Ali Munawar and George D. Hartman and is headquartered in Doylestown, PA. | Pharmaceuticals: Major | Chairman Chief Executive Officer Chief Operating Officer | |
Spybiotech Ltd.
![]() Spybiotech Ltd. BiotechnologyHealth Technology Spybiotech Ltd. develops molecular superglue which it believes can be used to create vaccines. The company was founded by Sumit Biswas and is headquartered in Oxford, the United Kingdom. | Biotechnology | Director/Board Member Director/Board Member | |
MiroBio Ltd.
![]() MiroBio Ltd. BiotechnologyHealth Technology Mirobio Ltd. operates as a biologics company focusing on autoimmune and inflammatory disorders. The firm develops antibody modulators of immune cell receptors, an approach that has potential across a range of diseases, with an initial focus on auto-immune disease. The company was founded by Richard Cornall and Simon Davis on October 8, 2018 and is headquartered in Oxford, the United Kingdom. | Biotechnology | Director/Board Member Director/Board Member | |
SR One Capital Management LP
![]() SR One Capital Management LP Investment ManagersFinance SR One Capital Management LP (SR One) is a venture capital firm founded in 2020. The firm is headquartered in Redwood, California. | Investment Managers | Consultant / Advisor Director/Board Member | |
We Are Pioneer Group Ltd.
![]() We Are Pioneer Group Ltd. Investment ManagersFinance We Are Pioneer Group Ltd. (Pioneer Group) is a venture capital firm founded in 2021. The firm is headquartered in London, United Kingdom. | Investment Managers | Private Equity Investor Director/Board Member | |
FoRx Therapeutics AG
![]() FoRx Therapeutics AG Pharmaceuticals: MajorHealth Technology FoRx Therapeutics AG operates as a biotechnology company developing a new generation of cancer drugs focusing on novel deoxyribonucleic acid (DNA) Replication Stress pathways activated in cancer. The firm also provides research and development services. The company was founded by Thanos Halazonetis and Sotirios K. Sotiriou in 2019 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Chairman Director/Board Member |
Estadísticas
Internacional
Reino Unido | 20 |
Estados Unidos | 19 |
Suiza | 5 |
Suecia | 4 |
Finlandia | 2 |
Sectorial
Health Technology | 24 |
Consumer Services | 12 |
Finance | 9 |
Commercial Services | 5 |
Technology Services | 3 |
Operativa
Director/Board Member | 611 |
Corporate Officer/Principal | 182 |
Chairman | 119 |
Independent Dir/Board Member | 110 |
Undergraduate Degree | 75 |
Las relaciones más conectadas
Insiders | |
---|---|
Reid Hoffman | 53 |
Johnson Chen | 42 |
William Guttman | 42 |
Simon Holden | 40 |
Elaine Jones | 37 |
George Golumbeski | 36 |
Johan Rutger Christenson | 35 |
Heather Elizabeth Preston | 34 |
Scott Rocklage | 32 |
Peter George Lutz | 31 |
Richard Alan Laxer | 29 |
Deborah Harland | 27 |
John Bell | 27 |
Colin Goddard | 26 |
Carole Nüchterlein | 26 |
- Bolsa de valores
- Insiders
- Jonathan Hepple
- Conexiones Empresas